RxDoctor Payments DataLook up a doctor →

Alok Goyal, MD

Internal Medicine · Milwaukee, WINPI 1487634036

Payments from drug & device makers

$7,407in general payments, 2019–2025

Across 405 payments — averaging $18.29 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson$1K
  • AstraZeneca$774
  • AbbVie$612
  • Otsuka America Pharmaceutical, Inc.$430
  • Astellas Pharma US Inc$379
  • Lilly USA, LLC$347
  • plus $4K from 54 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Johnson & Johnson85$1,204
AstraZeneca35$774
AbbVie(2 entities)35$612
Otsuka America Pharmaceutical, Inc.25$430
Astellas Pharma US Inc7$379
Lilly USA, LLC21$347
Neurocrine Biosciences, Inc.13$285
Nestle Healthcare Nutrition Inc.14$241
Bayer11$234
Pfizer13$231
Takeda Pharmaceuticals U.S.A., Inc.12$216
Sunovion Pharmaceuticals Inc.13$181
Gilead5$157
E.r. Squibb & Sons, L.L.C.7$149
Boehringer Ingelheim13$143
Novartis7$118
Amneal Pharmaceuticals LLC7$100
Axsome Therapeutics, Inc.4$96
Lundbeck LLC4$85
Teva Pharmaceuticals USA, Inc.4$79
Acadia Pharmaceuticals Inc5$79
Avanir Pharmaceuticals, Inc.4$74
Sanofi Pasteur Inc.4$63
Vanda Pharmaceuticals Inc.2$55
Collegium Pharmaceutical, Inc.3$51
Amphastar Pharmaceuticals, Inc.1$51
Aimmune Therapeutics, Inc.2$51
Scilex Pharmaceuticals Inc.3$48
Amarin Pharma, Inc.3$47
GSK2$46
Mallinckrodt Hospital Products Inc.2$46
Optinose US, Inc.2$44
Biogen2$42
Philips North America LLC1$36
Ultragenyx Pharmaceutical Inc.2$35
Exact Sciences2$34
Sun Pharmaceutical Industries Inc.2$33
Nevro Corp.1$32
GE HealthCare1$31
Indivior Inc.1$29
Shire North American Group Inc2$29
Ardelyx, Inc.1$25
Supernus Pharmaceuticals, Inc.1$22
Kyowa Kirin, Inc.1$21
Agios Pharmaceuticals, Inc.1$21
Ironwood Pharmaceuticals, Inc1$20
Regeneron Healthcare Solutions, Inc.1$20
Medtronic1$19
Novo Nordisk1$19
Alnylam Pharmaceuticals Inc.1$18
Insmed, Inc.1$17
QOL Medical, LLC1$16
Daiichi Sankyo Inc.1$16
MDD US Operations, LLC1$16
Sumitomo Pharma America, Inc.1$15
G Medical Diagnostic Services, Inc.1$15
Vivus LLC1$15
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC1$15
Cumberland Pharmaceuticals, Inc.1$14
Sanofi-aventis U.S. LLC1$14

How this compares

$7,407 in reported general payments places this provider in the 95th percentile of 1,411 internal medicine providers in Wisconsin.

See all internal medicine providers in Wisconsin

Medicare billing

Part B allowed, 2024
$397,281
Medicare patients
896
Services billed
3,930

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other internal medicine in Milwaukee

See the full list for Wisconsin

Where these figures come from

Is this you, or does something look wrong? →